{"adverse_reactions":["ADVERSE REACTIONS Iron: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) can occur but are usually mild and can subside with continuation of therapy. Although the absorption of iron is best when taken between meals, Multi-Nate DHA Extra 275/400 mg, when taken after meals, may control occasional G.I. disturbances, Multi-Nate DHA Extra 275/400 mg is best absorbed when taken at bedtime. Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at: 1-800-FDA-1088."],"contraindications":["CONTRAINDICATIONS Multi-Nate DHA Extra 275/400 mg is contraindicated in patients with a known hypersensitivity to any of the ingredients, including fish oil and soy. Iron is contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. This product is contraindicated for persons with pernicious anemia, as folic acid may obscure its signs and symptoms. WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive."],"description":["DESCRIPTION Multi-Nate DHA Extra 275/400 mg is a high-potency, multivitamin, multi-mineral nutritional supplement with DHA (Omega-3 Fatty Acid). Each Multi-Nate tablet contains: Other Ingredients (Multi-Nate tablet): Mono and Diglycerides, Croscarmellose Sodium, Maltodextrin, Microcrystalline Cellulose, Crospovidone, Stearic Acid, Hydroxypropyl Methylcellulose, Titanium Dioxide, Magnesium Stearate, Silicon Dioxide, Acacia, Sodium Alginate, Arabic Gum, Sucrose, Pea Starch, Cornstarch, Gelatin, Dicalcium Phosphate, Triacetin, Partially Hydrogenated Soybean Oil, Carmine Powder CFR 73.100/E120, Caramel Color CFR 73.85/E150, Polysorbate, Polyethylene Glycol. Contains Soy. Each Multi-Nate DHA Extra 275/400 mg enteric-coated softgel capsule contains: 275 mg Docosahexaenoic Acid (DHA) from 400 mg omega-3 fatty acids (tuna acid). Other Ingredients (Multi-Nate DHA Extra 275/400 mg enteric-coated softgel capsule): Gelatin, Water, Glycerin, Polysorbate 80, Ethycellulose, Sodium Alginate, Polyethylene Glycol, Oleic Acid, Fractionated Coconut Oil, Purified Stearic Acid, Ammonium Hydroxide. Also contains Eicosapentaenoic Acid (EPA) and other Omega-3 Fatty Acids (from tuna oil). Contains Soy and Fish Oil (from tuna oil). Contains NO artificial flavors or preservatives, yeast, wheat, gluten, nuts or milk-based by-products. WARNING: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six. Keep this and all drugs out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Multi-Nate tablet supplies important prenatal vitamins, minerals and nutrients to supplement the nutritional needs of women, before, during and after pregnancy. Deficiencies of these nutrients are common during pregnancy and lactation, and should be prescribed by a physician prior to conception. Multi-Nate tablet is manufactured in a drug-certified cGMP (current Good Manufacturing Practices) facility and meets or exceeds USP standards for potency, purity and dissolution. Multi-Nate DHA Extra 275/400 mg softgel capsule complies with the most stringent worldwide standards for fish oil and is manufactured in a NSF Certified cGMP Facility. facts1 facts2"],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Before, during and after pregnancy, adult women (over 12 years of age), take one (1) tablet and one (1) enteric-coated softgel capsule by mouth daily, between meals or as prescribed by a physician. Tablet and enteric-coated softgel capsule may be taken separately. Do not exceed the recommended dosage. Do not administer to children under 12 years of age or persons age 65 or older. Do not exceed one gram (1,000 mg) of DHA per day."],"effective_time":"20110421","how_supplied":["HOW SUPPLIED Multi-Nate DHA Extra 275/400 mg NDC: 68032-447-30 is a 30-day regimen supplied as one bottle of Multi-Nate NDC: 68032-340-30 containing 30 dark red tablets imprinted “RE 340” and one bottle of Multi-Nate DHA Extra 275/400 mg NDC: 68032-451-30, containing 30 yellow enteric-coated softgel capsules. Dispense in tight, light-resistant containers as defined in the USP/NF with child resistant closures. Store at controlled room temperature 15°-30°C (59°-86°F). Keep in a cool, dry place. CAUTION: Rx Only RESERVED FOR PROFESSIONAL RECOMMENDATION: Made in the USA exclusively for River’s Edge Pharmaceuticals, LLC, Suwanee, GA, 30024. All rights reserved. Copyright © by River’s Edge Pharmaceuticals."],"id":"e2254581-3357-4d1c-91b9-5bc8de84b5ca","indications_and_usage":["INDICATIONS AND USAGE Multi-Nate DHA Extra 275/400 mg is a prescription regimen of prenatal multivitamin, multi-mineral and omega-3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post-natal period for both lactating and non-lactating mothers. Multi-Nate DHA Extra 275/400 mg is also useful in improving the nutritional status prior to conception."],"openfda":{},"overdosage":["OVERDOSE Iron: Signs and Symptoms: Iron is toxic. Acute overdosage or iron may cause nausea and vomiting. In severe causes, iron overdose can cause cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities have resulted. Multi-Nate DHA Extra 275/400 mg should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of reach of children. Treatment: For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen."],"package_label_principal_display_panel":["PACKAGING carton"],"precautions":["PRECAUTIONS Folic acid in dosages above 400 mcg daily may obscure megaloblastic (pernicious) anemia in that hematological remission can occur while neurological manifestations (Addisonian anemia) remain progressive."],"set_id":"93244ee2-7462-4b29-9a52-2c95693b0d54","spl_product_data_elements":["Multinate DHA Extra BETA CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, IRON, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC OXIDE, OMEGA-3-ACID ETHYL ESTERS, DOCONEXENT Multinate BETA CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, IRON, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC OXIDE BETA CAROTENE BETA CAROTENE ASCORBIC ACID ASCORBIC ACID CHOLECALCIFEROL CHOLECALCIFEROL ALPHA-TOCOPHEROL ALPHA-TOCOPHEROL THIAMINE MONONITRATE THIAMINE RIBOFLAVIN RIBOFLAVIN NIACINAMIDE NIACINAMIDE PYRIDOXINE HYDROCHLORIDE PYRIDOXINE FOLIC ACID FOLIC ACID CYANOCOBALAMIN CYANOCOBALAMIN CALCIUM CARBONATE CALCIUM IRON IRON MAGNESIUM OXIDE MAGNESIUM ZINC OXIDE ZINC CUPRIC OXIDE CUPRIC CATION CAPRYLIC/CAPRIC MONO/DIGLYCERIDES CROSCARMELLOSE SODIUM CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE MALTODEXTRIN STEARIC ACID MAGNESIUM STEARATE SILICON DIOXIDE ACACIA SODIUM ALGINATE POLYETHYLENE GLYCOL SUCROSE STARCH, CORN HYDROGENATED SOYBEAN OIL HYPROMELLOSES ANHYDROUS DIBASIC CALCIUM PHOSPHATE GELATIN TITANIUM DIOXIDE TRIACETIN POLYSORBATE 20 dark red RE;340 Multinate DHA Extra OMEGA-3-ACID ETHYL ESTERS, DOCONEXENT OMEGA-3-ACID ETHYL ESTERS OMEGA-3-ACID ETHYL ESTERS DOCONEXENT DOCONEXENT GELATIN WATER GLYCERIN POLYSORBATE 80 SODIUM ALGINATE POLYETHYLENE GLYCOL MEDIUM-CHAIN TRIGLYCERIDES STEARIC ACID AMMONIA OLEIC ACID RE;451"],"use_in_specific_populations":["USE IN SPECIFIC POPULATIONS Multi-Nate DHA Extra 275/400 mg is not advocated for pediatric or geriatric use."],"version":"6","warnings":["WARNING Ingestion of omega-3 fatty acids (including alpha-linolenic acid [ALA], eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA] from fish oils) of more than 3 grams per day may present antithrombotic effects, including increased bleeding time. Omega-3 fatty acids including DHA and EPA should be avoided in patients with inherited or acquired bleeding diatheses. Patients taking anticoagulant drug products should consult with their physician prior to ingesting omega-3 fatty acids."]}